0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative

0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global Hydroxyprogesterone Caproate Injection Market Research Report 2026
Published Date: 2026-02-27
|
Report Code: QYRE-Auto-5U2673
Home | Market Reports | Health| Pharmacy
Global Hydroxyprogesterone Caproate Injection Market Size Manufacturers Supply Chain Sales Channel and Clients 2021 2027
BUY CHAPTERS

Global Hydroxyprogesterone Caproate Injection Market Research Report 2026

Code: QYRE-Auto-5U2673
Report
2026-02-27
Pages:105
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES

Hydroxyprogesterone Caproate Injection Market Size

The global Hydroxyprogesterone Caproate Injection market was valued at US$ 275 million in 2025 and is anticipated to reach US$ 304 million by 2032, at a CAGR of 1.5% from 2026 to 2032.

Hydroxyprogesterone Caproate Injection Market

Hydroxyprogesterone Caproate Injection Market

The 2025 U.S. tariff policies introduce profound uncertainty into the global economic landscape. This report critically examines the implications of recent tariff adjustments and international strategic countermeasures on Hydroxyprogesterone Caproate Injection competitive dynamics, regional economic interdependencies, and supply chain reconfigurations.
Hydroxyprogesterone caproate (OHPC), sold under the brand names Proluton and Makena among others, is a progestin medication which is used to prevent preterm birth in pregnant women with a history of the condition and to treat gynecological disorders.It has also been formulated in combination with estrogens for various indications (brand names Gravibinon and Primosiston) and as a form of long-lasting injectable birth control (brand name Chinese Injectable No. 1). It is not used by mouth and is instead given by injection into muscle or fat, typically once per week to once per month depending on the indication.
Global hydroxyprogesterone caproate injection main manufactuers include AMAG Pharmaceuticals, Mcguff Pharmaceuticals and Aspen, etc., totally holding a share for 97% of the market. North America is the largest market of hydroxyprogesterone caproate injection, with a share about 37%. As for the types of products, it can be divided into 1 ml injection(including 1.1 mL) and 5 ml injection. The most common product is 5 ml injection, with a share over 52%. In terms of applications, it is widely used in hospitals and clinics. The most commom application is in hospitals, with a share over 50%.
This report delivers a comprehensive overview of the global Hydroxyprogesterone Caproate Injection market, with both quantitative and qualitative analyses, to help readers develop growth strategies, assess the competitive landscape, evaluate their position in the current market, and make informed business decisions regarding Hydroxyprogesterone Caproate Injection. The Hydroxyprogesterone Caproate Injection market size, estimates, and forecasts are provided in terms of sales volume (K Units) and revenue (US$ millions), with 2025 as the base year and historical and forecast data for 2021–2032.
The report segments the global Hydroxyprogesterone Caproate Injection market comprehensively. Regional market sizes by Type, by Application, , and by company are also provided. For deeper insight, the report profiles the competitive landscape, key competitors, and their respective market rankings, and discusses technological trends and new product developments.
This report will assist Hydroxyprogesterone Caproate Injection manufacturers, new entrants, and companies across the industry value chain with information on revenues, sales volume, and average prices for the overall market and its sub-segments, by company, by Type, by Application, and by region.
Market Segmentation

Scope of Hydroxyprogesterone Caproate Injection Market Report

Report Metric Details
Report Name Hydroxyprogesterone Caproate Injection Market
Accounted market size in 2025 US$ 275 million
Forecasted market size in 2032 US$ 304 million
CAGR 1.5%
Base Year 2025
Forecasted years 2026 - 2032
Segment by Type
  • 1 mL Injection(Including 1.1 mL)
  • 5 mL Injection
by Application
  • Hospitals Injection
  • Clinics Injection
Consumption by Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia)
  • Asia-Pacific (China, Japan, South Korea, Taiwan)
  • Southeast Asia (India)
  • Latin America (Mexico, Brazil)
By Company AMAG Pharmaceuticals, Mcguff Pharmaceuticals Inc, Aspen Oss B.V, American Regent, Inc., Mylan Institutional
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

  • Chapter 1: Defines the scope of the report and presents an executive summary of market segments (by Type, by Application, , etc.), including the size of each segment and its future growth potential. It offers a high-level view of the current market and its likely evolution in the short, medium, and long term.
  • Chapter 2: Provides a detailed analysis of the competitive landscape for Hydroxyprogesterone Caproate Injection manufacturers, covering pricing, sales and revenue shares, latest development plans, and mergers and acquisitions.
  • Chapter 3: Examines Hydroxyprogesterone Caproate Injection sales and revenue at the regional and country levels. It quantifies market size and growth potential for each region and its key countries, and outlines market development, outlook, addressable space, and national market size.
  • Chapter 4: Analyzes segments by Type, detailing the size and growth potential of each segment to help readers identify “blue ocean” opportunities.
  • Chapter 5: Analyzes market segments by Application, covering the size and growth potential of each segment to help readers identify “blue ocean” opportunities in downstream markets.
  • Chapter 6: Profiles key players, presenting core information on leading companies, including product sales, revenue, pricing, gross margin, product portfolio/introductions, and recent developments.
  • Chapter 7: Reviews the industry value chain, including upstream and downstream segments.
  • Chapter 8: Discusses market dynamics and recent developments, including drivers, restraints, challenges and risks for manufacturers, U.S. Tariffs and relevant policy analysis.
  • Chapter 9: Summarizes the key findings and conclusions of the report.

FAQ for this report

How fast is Hydroxyprogesterone Caproate Injection Market growing?

Ans: The Hydroxyprogesterone Caproate Injection Market witnessing a CAGR of 1.5% during the forecast period 2026-2032.

What is the Hydroxyprogesterone Caproate Injection Market size in 2032?

Ans: The Hydroxyprogesterone Caproate Injection Market size in 2032 will be US$ 304 million.

What is the AMAG Pharmaceuticals share in Hydroxyprogesterone Caproate Injection Market?

Ans: Global hydroxyprogesterone caproate injection main manufactuers include AMAG Pharmaceuticals, Mcguff Pharmaceuticals and Aspen, etc., totally holding a share for 97% of the market.

What is the Hydroxyprogesterone Caproate Injection Market share by region?

Ans: North America is the largest market of hydroxyprogesterone caproate injection, with a share about 37%.

What is the Hydroxyprogesterone Caproate Injection Market share by type?

Ans: The most common product is 5 ml injection, with a share over 52%.

Who are the main players in the Hydroxyprogesterone Caproate Injection Market report?

Ans: The main players in the Hydroxyprogesterone Caproate Injection Market are AMAG Pharmaceuticals, Mcguff Pharmaceuticals Inc, Aspen Oss B.V, American Regent, Inc., Mylan Institutional

What are the Application segmentation covered in the Hydroxyprogesterone Caproate Injection Market report?

Ans: The Applications covered in the Hydroxyprogesterone Caproate Injection Market report are Hospitals Injection, Clinics Injection

What are the Type segmentation covered in the Hydroxyprogesterone Caproate Injection Market report?

Ans: The Types covered in the Hydroxyprogesterone Caproate Injection Market report are 1 mL Injection(Including 1.1 mL), 5 mL Injection

1 Hydroxyprogesterone Caproate Injection Market Overview
1.1 Product Definition
1.2 Hydroxyprogesterone Caproate Injection by Type
1.2.1 Global Hydroxyprogesterone Caproate Injection Market Value by Type: 2025 vs 2032
1.2.2 1 mL Injection(Including 1.1 mL)
1.2.3 5 mL Injection
1.3 Hydroxyprogesterone Caproate Injection by Application
1.3.1 Global Hydroxyprogesterone Caproate Injection Market Value by Application: 2025 vs 2032
1.3.2 Hospitals Injection
1.3.3 Clinics Injection
1.4 Global Hydroxyprogesterone Caproate Injection Market Size Estimates and Forecasts
1.4.1 Global Hydroxyprogesterone Caproate Injection Revenue 2021–2032
1.4.2 Global Hydroxyprogesterone Caproate Injection Sales 2021–2032
1.4.3 Global Hydroxyprogesterone Caproate Injection Market Average Price (2021–2032)
1.5 Assumptions and Limitations
2 Hydroxyprogesterone Caproate Injection Market Competition by Manufacturers
2.1 Global Hydroxyprogesterone Caproate Injection Sales Market Share by Manufacturers (2021–2026)
2.2 Global Hydroxyprogesterone Caproate Injection Revenue Market Share by Manufacturers (2021–2026)
2.3 Global Hydroxyprogesterone Caproate Injection Average Price by Manufacturers (2021–2026)
2.4 Global Key Players of Hydroxyprogesterone Caproate Injection, Industry Ranking, 2023 vs 2024 vs 2025
2.5 Global Key Manufacturers of Hydroxyprogesterone Caproate Injection, Manufacturing Sites and Headquarters
2.6 Global Key Manufacturers of Hydroxyprogesterone Caproate Injection, Product Types and Applications
2.7 Global Key Manufacturers of Hydroxyprogesterone Caproate Injection, Date of Entry into the Industry
2.8 Global Hydroxyprogesterone Caproate Injection Market Competitive Situation and Trends
2.8.1 Global Hydroxyprogesterone Caproate Injection Market Concentration Rate
2.8.2 The Top 5 and Top 10 Global Hydroxyprogesterone Caproate Injection Players Market Share by Revenue
2.8.3 Global Hydroxyprogesterone Caproate Injection Market Share by Company Tier (Tier 1, Tier 2, Tier 3)
2.9 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Global Hydroxyprogesterone Caproate Injection Market Scenario by Region
3.1 Global Hydroxyprogesterone Caproate Injection Market Size by Region: 2021 vs 2025 vs 2032
3.2 Global Hydroxyprogesterone Caproate Injection Sales by Region: 2021–2032
3.2.1 Global Hydroxyprogesterone Caproate Injection Sales by Region: 2021–2026
3.2.2 Global Hydroxyprogesterone Caproate Injection Sales by Region: 2027–2032
3.3 Global Hydroxyprogesterone Caproate Injection Revenue by Region: 2021–2032
3.3.1 Global Hydroxyprogesterone Caproate Injection Revenue by Region: 2021–2026
3.3.2 Global Hydroxyprogesterone Caproate Injection Revenue by Region: 2027–2032
3.4 North America Hydroxyprogesterone Caproate Injection Market Facts & Figures by Country
3.4.1 North America Hydroxyprogesterone Caproate Injection Market Size by Country: 2021 vs 2025 vs 2032
3.4.2 North America Hydroxyprogesterone Caproate Injection Sales by Country (2021–2032)
3.4.3 North America Hydroxyprogesterone Caproate Injection Revenue by Country (2021–2032)
3.4.4 U.S.
3.4.5 Canada
3.5 Europe Hydroxyprogesterone Caproate Injection Market Facts & Figures by Country
3.5.1 Europe Hydroxyprogesterone Caproate Injection Market Size by Country: 2021 vs 2025 vs 2032
3.5.2 Europe Hydroxyprogesterone Caproate Injection Sales by Country (2021–2032)
3.5.3 Europe Hydroxyprogesterone Caproate Injection Revenue by Country (2021–2032)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Hydroxyprogesterone Caproate Injection Market Facts & Figures by Region
3.6.1 Asia Pacific Hydroxyprogesterone Caproate Injection Market Size by Region: 2021 vs 2025 vs 2032
3.6.2 Asia Pacific Hydroxyprogesterone Caproate Injection Sales by Region (2021–2032)
3.6.3 Asia Pacific Hydroxyprogesterone Caproate Injection Revenue by Region (2021–2032)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.6.13 Philippines
3.7 Latin America Hydroxyprogesterone Caproate Injection Market Facts & Figures by Country
3.7.1 Latin America Hydroxyprogesterone Caproate Injection Market Size by Country: 2021 vs 2025 vs 2032
3.7.2 Latin America Hydroxyprogesterone Caproate Injection Sales by Country (2021–2032)
3.7.3 Latin America Hydroxyprogesterone Caproate Injection Revenue by Country (2021–2032)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Hydroxyprogesterone Caproate Injection Market Facts & Figures by Country
3.8.1 Middle East and Africa Hydroxyprogesterone Caproate Injection Market Size by Country: 2021 vs 2025 vs 2032
3.8.2 Middle East and Africa Hydroxyprogesterone Caproate Injection Sales by Country (2021–2032)
3.8.3 Middle East and Africa Hydroxyprogesterone Caproate Injection Revenue by Country (2021–2032)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Hydroxyprogesterone Caproate Injection Sales by Type (2021–2032)
4.1.1 Global Hydroxyprogesterone Caproate Injection Sales by Type (2021–2026)
4.1.2 Global Hydroxyprogesterone Caproate Injection Sales by Type (2027–2032)
4.1.3 Global Hydroxyprogesterone Caproate Injection Sales Market Share by Type (2021–2032)
4.2 Global Hydroxyprogesterone Caproate Injection Revenue by Type (2021–2032)
4.2.1 Global Hydroxyprogesterone Caproate Injection Revenue by Type (2021–2026)
4.2.2 Global Hydroxyprogesterone Caproate Injection Revenue by Type (2027–2032)
4.2.3 Global Hydroxyprogesterone Caproate Injection Revenue Market Share by Type (2021–2032)
4.3 Global Hydroxyprogesterone Caproate Injection Price by Type (2021–2032)
5 Segment by Application
5.1 Global Hydroxyprogesterone Caproate Injection Sales by Application (2021–2032)
5.1.1 Global Hydroxyprogesterone Caproate Injection Sales by Application (2021–2026)
5.1.2 Global Hydroxyprogesterone Caproate Injection Sales by Application (2027–2032)
5.1.3 Global Hydroxyprogesterone Caproate Injection Sales Market Share by Application (2021–2032)
5.2 Global Hydroxyprogesterone Caproate Injection Revenue by Application (2021–2032)
5.2.1 Global Hydroxyprogesterone Caproate Injection Revenue by Application (2021–2026)
5.2.2 Global Hydroxyprogesterone Caproate Injection Revenue by Application (2027–2032)
5.2.3 Global Hydroxyprogesterone Caproate Injection Revenue Market Share by Application (2021–2032)
5.3 Global Hydroxyprogesterone Caproate Injection Price by Application (2021–2032)
6 Key Companies Profiled
6.1 AMAG Pharmaceuticals
6.1.1 AMAG Pharmaceuticals Company Information
6.1.2 AMAG Pharmaceuticals Description and Business Overview
6.1.3 AMAG Pharmaceuticals Hydroxyprogesterone Caproate Injection Sales, Revenue, and Gross Margin (2021–2026)
6.1.4 AMAG Pharmaceuticals Hydroxyprogesterone Caproate Injection Product Portfolio
6.1.5 AMAG Pharmaceuticals Recent Developments/Updates
6.2 Mcguff Pharmaceuticals Inc
6.2.1 Mcguff Pharmaceuticals Inc Company Information
6.2.2 Mcguff Pharmaceuticals Inc Description and Business Overview
6.2.3 Mcguff Pharmaceuticals Inc Hydroxyprogesterone Caproate Injection Sales, Revenue, and Gross Margin (2021–2026)
6.2.4 Mcguff Pharmaceuticals Inc Hydroxyprogesterone Caproate Injection Product Portfolio
6.2.5 Mcguff Pharmaceuticals Inc Recent Developments/Updates
6.3 Aspen Oss B.V
6.3.1 Aspen Oss B.V Company Information
6.3.2 Aspen Oss B.V Description and Business Overview
6.3.3 Aspen Oss B.V Hydroxyprogesterone Caproate Injection Sales, Revenue, and Gross Margin (2021–2026)
6.3.4 Aspen Oss B.V Hydroxyprogesterone Caproate Injection Product Portfolio
6.3.5 Aspen Oss B.V Recent Developments/Updates
6.4 American Regent, Inc.
6.4.1 American Regent, Inc. Company Information
6.4.2 American Regent, Inc. Description and Business Overview
6.4.3 American Regent, Inc. Hydroxyprogesterone Caproate Injection Sales, Revenue, and Gross Margin (2021–2026)
6.4.4 American Regent, Inc. Hydroxyprogesterone Caproate Injection Product Portfolio
6.4.5 American Regent, Inc. Recent Developments/Updates
6.5 Mylan Institutional
6.5.1 Mylan Institutional Company Information
6.5.2 Mylan Institutional Description and Business Overview
6.5.3 Mylan Institutional Hydroxyprogesterone Caproate Injection Sales, Revenue, and Gross Margin (2021–2026)
6.5.4 Mylan Institutional Hydroxyprogesterone Caproate Injection Product Portfolio
6.5.5 Mylan Institutional Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Hydroxyprogesterone Caproate Injection Industry Chain Analysis
7.2 Hydroxyprogesterone Caproate Injection Raw Material Supply Analysis
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Hydroxyprogesterone Caproate Injection Production Mode & Process Analysis
7.4 Hydroxyprogesterone Caproate Injection Sales and Marketing
7.4.1 Hydroxyprogesterone Caproate Injection Sales Channels
7.4.2 Hydroxyprogesterone Caproate Injection Distributors
7.5 Hydroxyprogesterone Caproate Injection Customer Analysis
8 Hydroxyprogesterone Caproate Injection Market Dynamics
8.1 Hydroxyprogesterone Caproate Injection Industry Trends
8.2 Hydroxyprogesterone Caproate Injection Market Drivers
8.3 Hydroxyprogesterone Caproate Injection Market Challenges
8.4 Hydroxyprogesterone Caproate Injection Market Restraints
8.5 Impact of U.S. Tariffs
9 Research Findings and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
List of Tables
 Table 1. Global Hydroxyprogesterone Caproate Injection Market Value by Type (US$ Million), 2025 vs 2032
 Table 2. Global Hydroxyprogesterone Caproate Injection Market Value by Application (US$ Million), 2025 vs 2032
 Table 3. Global Hydroxyprogesterone Caproate Injection Market Competitive Situation by Manufacturers in 2025
 Table 4. Global Hydroxyprogesterone Caproate Injection Sales (K Units) of Key Manufacturers (2021–2026)
 Table 5. Global Hydroxyprogesterone Caproate Injection Sales Market Share by Manufacturers (2021–2026)
 Table 6. Global Hydroxyprogesterone Caproate Injection Revenue (US$ Million) by Manufacturers (2021–2026)
 Table 7. Global Hydroxyprogesterone Caproate Injection Revenue Share by Manufacturers (2021–2026)
 Table 8. Global Market Hydroxyprogesterone Caproate Injection Average Price (US$/Unit) of Key Manufacturers (2021–2026)
 Table 9. Global Key Players of Hydroxyprogesterone Caproate Injection, Industry Ranking, 2023 vs 2024 vs 2025
 Table 10. Global Key Manufacturers of Hydroxyprogesterone Caproate Injection, Manufacturing Sites and Headquarters
 Table 11. Global Key Manufacturers of Hydroxyprogesterone Caproate Injection, Product Types and Applications
 Table 12. Global Key Manufacturers of Hydroxyprogesterone Caproate Injection, Date of Entry into the Industry
 Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
 Table 14. Global Hydroxyprogesterone Caproate Injection Companies by Tier (Tier 1, Tier 2, Tier 3), based on Hydroxyprogesterone Caproate Injection Revenue, 2025
 Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
 Table 16. Global Hydroxyprogesterone Caproate Injection Market Size by Region (US$ Million): 2021 vs 2025 vs 2032
 Table 17. Global Hydroxyprogesterone Caproate Injection Sales by Region (K Units), 2021–2026
 Table 18. Global Hydroxyprogesterone Caproate Injection Sales Market Share by Region (2021–2026)
 Table 19. Global Hydroxyprogesterone Caproate Injection Sales by Region (K Units), 2027–2032
 Table 20. Global Hydroxyprogesterone Caproate Injection Sales Market Share by Region (2027–2032)
 Table 21. Global Hydroxyprogesterone Caproate Injection Revenue by Region (US$ Million), 2021–2026
 Table 22. Global Hydroxyprogesterone Caproate Injection Revenue Market Share by Region (2021–2026)
 Table 23. Global Hydroxyprogesterone Caproate Injection Revenue by Region (US$ Million), 2027–2032
 Table 24. Global Hydroxyprogesterone Caproate Injection Revenue Market Share by Region (2027–2032)
 Table 25. North America Hydroxyprogesterone Caproate Injection Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)
 Table 26. North America Hydroxyprogesterone Caproate Injection Sales by Country (K Units), 2021–2026
 Table 27. North America Hydroxyprogesterone Caproate Injection Sales by Country (K Units), 2027–2032
 Table 28. North America Hydroxyprogesterone Caproate Injection Revenue by Country (US$ Million), 2021–2026
 Table 29. North America Hydroxyprogesterone Caproate Injection Revenue by Country (US$ Million), 2027–2032
 Table 30. Europe Hydroxyprogesterone Caproate Injection Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)
 Table 31. Europe Hydroxyprogesterone Caproate Injection Sales by Country (K Units), 2021–2026
 Table 32. Europe Hydroxyprogesterone Caproate Injection Sales by Country (K Units), 2027–2032
 Table 33. Europe Hydroxyprogesterone Caproate Injection Revenue by Country (US$ Million), 2021–2026
 Table 34. Europe Hydroxyprogesterone Caproate Injection Revenue by Country (US$ Million), 2027–2032
 Table 35. Asia Pacific Hydroxyprogesterone Caproate Injection Revenue by Region: 2021 vs 2025 vs 2032 (US$ Million)
 Table 36. Asia Pacific Hydroxyprogesterone Caproate Injection Sales by Region (K Units), 2021–2026
 Table 37. Asia Pacific Hydroxyprogesterone Caproate Injection Sales by Region (K Units), 2027–2032
 Table 38. Asia Pacific Hydroxyprogesterone Caproate Injection Revenue by Region (US$ Million), 2021–2026
 Table 39. Asia Pacific Hydroxyprogesterone Caproate Injection Revenue by Region (US$ Million), 2027–2032
 Table 40. Latin America Hydroxyprogesterone Caproate Injection Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)
 Table 41. Latin America Hydroxyprogesterone Caproate Injection Sales by Country (K Units), 2021–2026
 Table 42. Latin America Hydroxyprogesterone Caproate Injection Sales by Country (K Units), 2027–2032
 Table 43. Latin America Hydroxyprogesterone Caproate Injection Revenue by Country (US$ Million), 2021–2026
 Table 44. Latin America Hydroxyprogesterone Caproate Injection Revenue by Country (US$ Million), 2027–2032
 Table 45. Middle East and Africa Hydroxyprogesterone Caproate Injection Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)
 Table 46. Middle East and Africa Hydroxyprogesterone Caproate Injection Sales by Country (K Units), 2021–2026
 Table 47. Middle East and Africa Hydroxyprogesterone Caproate Injection Sales by Country (K Units), 2027–2032
 Table 48. Middle East and Africa Hydroxyprogesterone Caproate Injection Revenue by Country (US$ Million), 2021–2026
 Table 49. Middle East and Africa Hydroxyprogesterone Caproate Injection Revenue by Country (US$ Million), 2027–2032
 Table 50. Global Hydroxyprogesterone Caproate Injection Sales (K Units) by Type (2021–2026)
 Table 51. Global Hydroxyprogesterone Caproate Injection Sales (K Units) by Type (2027–2032)
 Table 52. Global Hydroxyprogesterone Caproate Injection Sales Market Share by Type (2021–2026)
 Table 53. Global Hydroxyprogesterone Caproate Injection Sales Market Share by Type (2027–2032)
 Table 54. Global Hydroxyprogesterone Caproate Injection Revenue (US$ Million) by Type (2021–2026)
 Table 55. Global Hydroxyprogesterone Caproate Injection Revenue (US$ Million) by Type (2027–2032)
 Table 56. Global Hydroxyprogesterone Caproate Injection Revenue Market Share by Type (2021–2026)
 Table 57. Global Hydroxyprogesterone Caproate Injection Revenue Market Share by Type (2027–2032)
 Table 58. Global Hydroxyprogesterone Caproate Injection Price (US$/Unit) by Type (2021–2026)
 Table 59. Global Hydroxyprogesterone Caproate Injection Price (US$/Unit) by Type (2027–2032)
 Table 60. Global Hydroxyprogesterone Caproate Injection Sales (K Units) by Application (2021–2026)
 Table 61. Global Hydroxyprogesterone Caproate Injection Sales (K Units) by Application (2027–2032)
 Table 62. Global Hydroxyprogesterone Caproate Injection Sales Market Share by Application (2021–2026)
 Table 63. Global Hydroxyprogesterone Caproate Injection Sales Market Share by Application (2027–2032)
 Table 64. Global Hydroxyprogesterone Caproate Injection Revenue (US$ Million) by Application (2021–2026)
 Table 65. Global Hydroxyprogesterone Caproate Injection Revenue (US$ Million) by Application (2027–2032)
 Table 66. Global Hydroxyprogesterone Caproate Injection Revenue Market Share by Application (2021–2026)
 Table 67. Global Hydroxyprogesterone Caproate Injection Revenue Market Share by Application (2027–2032)
 Table 68. Global Hydroxyprogesterone Caproate Injection Price (US$/Unit) by Application (2021–2026)
 Table 69. Global Hydroxyprogesterone Caproate Injection Price (US$/Unit) by Application (2027–2032)
 Table 70. AMAG Pharmaceuticals Company Information
 Table 71. AMAG Pharmaceuticals Description and Business Overview
 Table 72. AMAG Pharmaceuticals Hydroxyprogesterone Caproate Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
 Table 73. AMAG Pharmaceuticals Hydroxyprogesterone Caproate Injection Product
 Table 74. AMAG Pharmaceuticals Recent Developments/Updates
 Table 75. Mcguff Pharmaceuticals Inc Company Information
 Table 76. Mcguff Pharmaceuticals Inc Description and Business Overview
 Table 77. Mcguff Pharmaceuticals Inc Hydroxyprogesterone Caproate Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
 Table 78. Mcguff Pharmaceuticals Inc Hydroxyprogesterone Caproate Injection Product
 Table 79. Mcguff Pharmaceuticals Inc Recent Developments/Updates
 Table 80. Aspen Oss B.V Company Information
 Table 81. Aspen Oss B.V Description and Business Overview
 Table 82. Aspen Oss B.V Hydroxyprogesterone Caproate Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
 Table 83. Aspen Oss B.V Hydroxyprogesterone Caproate Injection Product
 Table 84. Aspen Oss B.V Recent Developments/Updates
 Table 85. American Regent, Inc. Company Information
 Table 86. American Regent, Inc. Description and Business Overview
 Table 87. American Regent, Inc. Hydroxyprogesterone Caproate Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
 Table 88. American Regent, Inc. Hydroxyprogesterone Caproate Injection Product
 Table 89. American Regent, Inc. Recent Developments/Updates
 Table 90. Mylan Institutional Company Information
 Table 91. Mylan Institutional Description and Business Overview
 Table 92. Mylan Institutional Hydroxyprogesterone Caproate Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
 Table 93. Mylan Institutional Hydroxyprogesterone Caproate Injection Product
 Table 94. Mylan Institutional Recent Developments/Updates
 Table 95. Key Raw Materials Lists
 Table 96. Raw Materials Key Suppliers Lists
 Table 97. Hydroxyprogesterone Caproate Injection Distributors List
 Table 98. Hydroxyprogesterone Caproate Injection Customers List
 Table 99. Hydroxyprogesterone Caproate Injection Market Trends
 Table 100. Hydroxyprogesterone Caproate Injection Market Drivers
 Table 101. Hydroxyprogesterone Caproate Injection Market Challenges
 Table 102. Hydroxyprogesterone Caproate Injection Market Restraints
 Table 103. Research Programs/Design for This Report
 Table 104. Key Data Information from Secondary Sources
 Table 105. Key Data Information from Primary Sources
 Table 106. Authors List of This Report


List of Figures
 Figure 1. Product Picture of Hydroxyprogesterone Caproate Injection
 Figure 2. Global Hydroxyprogesterone Caproate Injection Market Value by Type (US$ Million), 2021–2032
 Figure 3. Global Hydroxyprogesterone Caproate Injection Market Share by Type: 2025 & 2032
 Figure 4. 1 mL Injection(Including 1.1 mL) Product Picture
 Figure 5. 5 mL Injection Product Picture
 Figure 6. Global Hydroxyprogesterone Caproate Injection Market Value by Application (US$ Million), 2021–2032
 Figure 7. Global Hydroxyprogesterone Caproate Injection Market Share by Application: 2025 & 2032
 Figure 8. Hospitals Injection
 Figure 9. Clinics Injection
 Figure 10. Global Hydroxyprogesterone Caproate Injection Revenue, (US$ Million), 2021 vs 2025 vs 2032
 Figure 11. Global Hydroxyprogesterone Caproate Injection Market Size (US$ Million), 2021–2032
 Figure 12. Global Hydroxyprogesterone Caproate Injection Sales (K Units), 2021–2032
 Figure 13. Global Hydroxyprogesterone Caproate Injection Average Price (US$/Unit), 2021–2032
 Figure 14. Hydroxyprogesterone Caproate Injection Report Years Considered
 Figure 15. Hydroxyprogesterone Caproate Injection Sales Share by Manufacturers in 2025
 Figure 16. Global Hydroxyprogesterone Caproate Injection Revenue Share by Manufacturers in 2025
 Figure 17. Top 5 and Top 10 Global Hydroxyprogesterone Caproate Injection Players: Market Share by Revenue in Hydroxyprogesterone Caproate Injection in 2025
 Figure 18. Hydroxyprogesterone Caproate Injection Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2021 vs 2025
 Figure 19. Global Hydroxyprogesterone Caproate Injection Market Size by Region (US$ Million): 2021 vs 2025 vs 2032
 Figure 20. North America Hydroxyprogesterone Caproate Injection Sales Market Share by Country (2021–2032)
 Figure 21. North America Hydroxyprogesterone Caproate Injection Revenue Market Share by Country (2021–2032)
 Figure 22. U.S. Hydroxyprogesterone Caproate Injection Revenue Growth Rate (US$ Million), 2021–2032
 Figure 23. Canada Hydroxyprogesterone Caproate Injection Revenue Growth Rate (US$ Million), 2021–2032
 Figure 24. Europe Hydroxyprogesterone Caproate Injection Sales Market Share by Country (2021–2032)
 Figure 25. Europe Hydroxyprogesterone Caproate Injection Revenue Market Share by Country (2021–2032)
 Figure 26. Germany Hydroxyprogesterone Caproate Injection Revenue Growth Rate (US$ Million), 2021–2032
 Figure 27. France Hydroxyprogesterone Caproate Injection Revenue Growth Rate (US$ Million), 2021–2032
 Figure 28. U.K. Hydroxyprogesterone Caproate Injection Revenue Growth Rate (US$ Million), 2021–2032
 Figure 29. Italy Hydroxyprogesterone Caproate Injection Revenue Growth Rate (US$ Million), 2021–2032
 Figure 30. Russia Hydroxyprogesterone Caproate Injection Revenue Growth Rate (US$ Million), 2021–2032
 Figure 31. Asia Pacific Hydroxyprogesterone Caproate Injection Sales Market Share by Region (2021–2032)
 Figure 32. Asia Pacific Hydroxyprogesterone Caproate Injection Revenue Market Share by Region (2021–2032)
 Figure 33. China Hydroxyprogesterone Caproate Injection Revenue Growth Rate (US$ Million), 2021–2032
 Figure 34. Japan Hydroxyprogesterone Caproate Injection Revenue Growth Rate (US$ Million), 2021–2032
 Figure 35. South Korea Hydroxyprogesterone Caproate Injection Revenue Growth Rate (US$ Million), 2021–2032
 Figure 36. India Hydroxyprogesterone Caproate Injection Revenue Growth Rate (US$ Million), 2021–2032
 Figure 37. Australia Hydroxyprogesterone Caproate Injection Revenue Growth Rate (US$ Million), 2021–2032
 Figure 38. Taiwan Hydroxyprogesterone Caproate Injection Revenue Growth Rate (US$ Million), 2021–2032
 Figure 39. Indonesia Hydroxyprogesterone Caproate Injection Revenue Growth Rate (US$ Million), 2021–2032
 Figure 40. Thailand Hydroxyprogesterone Caproate Injection Revenue Growth Rate (US$ Million), 2021–2032
 Figure 41. Malaysia Hydroxyprogesterone Caproate Injection Revenue Growth Rate (US$ Million), 2021–2032
 Figure 42. Philippines Hydroxyprogesterone Caproate Injection Revenue Growth Rate (US$ Million), 2021–2032
 Figure 43. Latin America Hydroxyprogesterone Caproate Injection Sales Market Share by Country (2021–2032)
 Figure 44. Latin America Hydroxyprogesterone Caproate Injection Revenue Market Share by Country (2021–2032)
 Figure 45. Mexico Hydroxyprogesterone Caproate Injection Revenue Growth Rate (US$ Million), 2021–2032
 Figure 46. Brazil Hydroxyprogesterone Caproate Injection Revenue Growth Rate (US$ Million), 2021–2032
 Figure 47. Argentina Hydroxyprogesterone Caproate Injection Revenue Growth Rate (US$ Million), 2021–2032
 Figure 48. Middle East and Africa Hydroxyprogesterone Caproate Injection Sales Market Share by Country (2021–2032)
 Figure 49. Middle East and Africa Hydroxyprogesterone Caproate Injection Revenue Market Share by Country (2021–2032)
 Figure 50. Turkey Hydroxyprogesterone Caproate Injection Revenue Growth Rate (US$ Million), 2021–2032
 Figure 51. Saudi Arabia Hydroxyprogesterone Caproate Injection Revenue Growth Rate (US$ Million), 2021–2032
 Figure 52. UAE Hydroxyprogesterone Caproate Injection Revenue Growth Rate (US$ Million), 2021–2032
 Figure 53. Global Sales Market Share of Hydroxyprogesterone Caproate Injection by Type (2021–2032)
 Figure 54. Global Revenue Market Share of Hydroxyprogesterone Caproate Injection by Type (2021–2032)
 Figure 55. Global Hydroxyprogesterone Caproate Injection Price (US$/Unit) by Type (2021–2032)
 Figure 56. Global Sales Market Share of Hydroxyprogesterone Caproate Injection by Application (2021–2032)
 Figure 57. Global Revenue Market Share of Hydroxyprogesterone Caproate Injection by Application (2021–2032)
 Figure 58. Global Hydroxyprogesterone Caproate Injection Price (US$/Unit) by Application (2021–2032)
 Figure 59. Hydroxyprogesterone Caproate Injection Value Chain
 Figure 60. Channels of Distribution (Direct Vs Distribution)
 Figure 61. Bottom-up and Top-down Approaches for This Report
 Figure 62. Data Triangulation
 Figure 63. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic

$2900

Single User License
Electronic

$4350

Multi User License
Electronic

$5800

Enterprise License
Add to Cart
Buy Now (15% Discount)

OUR CUSTOMER

Seventh Sense AI